SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,376.23 -568.05
( -0.74%)

Global Indices

Nasdaq

52,794.59 -412.31
(-0.77%)

Dow Jones

7,653.60 -53.54
(-0.69%)

Hang Seng

66,431.13 119.20
(0.18%)

Nikkei 225

10,792.77 -31.49
(-0.29%)

Forex

USD-INR

95.24 -0.24
(-0.25%)

EUR-INR

110.49 -0.08
(-0.07%)

GBP-INR

128.99 -0.20
(-0.15%)

JPY-INR

0.60 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Welcure Drugs & Pharmaceuticals Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

524661

INE331C01025

0.785022

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

30.9

EPS(TTM)

Face Value()

Div & Yield %

Back

Bliss GVS Pharma consolidated net profit rises 16.40% in the June 2026 quarter

Aug 13,2026

Net profit of Bliss GVS Pharma rose 16.40% to Rs 50.10 crore in the quarter ended June 2026 as against Rs 43.04 crore during the previous quarter ended June 2025. Sales rose 37.65% to Rs 285.58 crore in the quarter ended June 2026 as against Rs 207.47 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	285.58	207.47	38
OPM %	26.75	19.92	-
PBDT	85.42	71.31	20
PBT	75.48	63.11	20
NP	50.10	43.04	16

76,376.23 -568.05 ( -0.74%)

52,794.59 -412.31 (-0.77%)

7,653.60 -53.54 (-0.69%)

66,431.13 119.20 (0.18%)

10,792.77 -31.49 (-0.29%)

95.24 -0.24 (-0.25%)

110.49 -0.08 (-0.07%)

128.99 -0.20 (-0.15%)

0.60 0.00 (-0.03%)